Aurora Cannabis (ACB) Capital Expenditures (2017 - 2025)
Aurora Cannabis (ACB) posted quarterly Capital Expenditures of $20.6 million for Q1 2025, down 1.04% year-over-year from $20.9 million in Q1 2024, and up 693.35% quarter-over-quarter from -$3.5 million in Q4 2024.
Aurora Cannabis (ACB) Capital Expenditures (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Capital Expenditures for 9 consecutive years, with $20.6 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Capital Expenditures fell 1.04% year-over-year to $20.6 million; the TTM figure through Mar 2025 stood at $10.1 million (up 44.7% YoY), while the FY2026 annual figure was $16.4 million, up 51.81% from the prior year.
- Capital Expenditures climbed to $20.6 million in Q1 2025 per ACB's latest filing, from -$3.5 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $77.2 million in Q2 2021 and bottomed at -$9.6 million in Q1 2021.
- Historically, Capital Expenditures has averaged $3.6 million across 5 years, with a median of -$3.8 million in 2024.
- Annual changes were most pronounced in 2021 — Capital Expenditures soared 415.35% — and 2022, when it slumped 105.99%.
- Aurora Cannabis' Capital Expenditures stood at -$8.9 million in 2021, then increased by 2.21% to -$8.7 million in 2022, then jumped by 76.66% to -$2.0 million in 2023, then plunged by 70.55% to -$3.5 million in 2024, then soared by 693.35% to $20.6 million in 2025.
- Business Quant data shows ACB's Capital Expenditures at $20.6 million in Q1 2025, -$3.5 million in Q4 2024, and -$3.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | -3.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 20.63 Mn |
| Mar 31, 2025 | 20.63 Mn |
| Dec 31, 2024 | -3.48 Mn |
| Dec 31, 2024 | -3.48 Mn |
| Sep 30, 2024 | -3.33 Mn |
| Sep 30, 2024 | -3.33 Mn |
| Jun 30, 2024 | -3.77 Mn |
| Jun 30, 2024 | -3.77 Mn |
| Mar 31, 2024 | 20.85 Mn |
| Mar 31, 2024 | 20.85 Mn |
| Dec 31, 2023 | -2.04 Mn |
| Dec 31, 2023 | -2.04 Mn |
| Sep 30, 2023 | -3.12 Mn |
| Sep 30, 2023 | -3.12 Mn |
| Dec 31, 2022 | -8.74 Mn |
| Dec 31, 2022 | -8.74 Mn |
| Sep 30, 2022 | -7.96 Mn |
| Sep 30, 2022 | -7.96 Mn |
| Jun 30, 2022 | -4.63 Mn |
| Jun 30, 2022 | -4.63 Mn |